These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22300037)

  • 1. α7 nicotinic acetylcholine receptors: a therapeutic target in the structure era.
    Taly A; Charon S
    Curr Drug Targets; 2012 May; 13(5):695-706. PubMed ID: 22300037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
    Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
    J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The α7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets?
    Thomsen MS; Mikkelsen JD
    Curr Drug Targets; 2012 May; 13(5):707-20. PubMed ID: 22300038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new "era" for the α7-nAChR.
    Russo P; Cardinale A; Shuller H
    Curr Drug Targets; 2012 May; 13(5):721-5. PubMed ID: 22300040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Targeting of
    Papke RL; Horenstein NA
    Pharmacol Rev; 2021 Jul; 73(3):1118-1149. PubMed ID: 34301823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation to the special issue: "α7-nicotinic receptor (α7-nAChR): one target different diseases".
    Russo P; Cesario A; Cardinale A
    Curr Drug Targets; 2012 May; 13(5):573. PubMed ID: 22564210
    [No Abstract]   [Full Text] [Related]  

  • 7. α7-Nicotinic receptors and cognition.
    Levin ED
    Curr Drug Targets; 2012 May; 13(5):602-6. PubMed ID: 22300026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α7-Nicotinic acetylcholine receptors: an old actor for new different roles.
    Russo P; Taly A
    Curr Drug Targets; 2012 May; 13(5):574-8. PubMed ID: 22300022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress and the α7 nicotinic acetylcholine receptor.
    Hunter RG
    Curr Drug Targets; 2012 May; 13(5):607-12. PubMed ID: 22300027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective alpha7 nicotinic acetylcholine receptor ligands.
    Mazurov A; Hauser T; Miller CH
    Curr Med Chem; 2006; 13(13):1567-84. PubMed ID: 16787204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain.
    Christensen DZ; Mikkelsen JD; Hansen HH; Thomsen MS
    J Neurochem; 2010 Aug; 114(4):1205-16. PubMed ID: 20533993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening.
    Dey R; Chen L
    J Biomol Struct Dyn; 2011 Apr; 28(5):695-715. PubMed ID: 21294583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia.
    Ishikawa M; Hashimoto K
    Curr Pharm Des; 2011; 17(2):121-9. PubMed ID: 21355839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptor pharmacology in silico: Insights and challenges.
    Gulsevin A
    Neuropharmacology; 2020 Oct; 177():108257. PubMed ID: 32738311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
    Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of α7-nicotinic acetylcholine receptor in normal and cancer stem cells.
    Lin W; Hirata N; Sekino Y; Kanda Y
    Curr Drug Targets; 2012 May; 13(5):656-65. PubMed ID: 22300032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future.
    Terry AV; Callahan PM
    Neuropharmacology; 2020 Jun; 170():108053. PubMed ID: 32188568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
    Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
    J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular function of α7 nicotinic receptors as drug targets.
    Bouzat C; Lasala M; Nielsen BE; Corradi J; Esandi MDC
    J Physiol; 2018 May; 596(10):1847-1861. PubMed ID: 29131336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
    Peng W; Ding F
    Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.